Page 2 - Robertp Charrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advertisement 340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute Wednesday, May 26, 2021 On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six pharmaceutical manufacturers stating that the manufacturers’ actions to limit access to 340B Program pricing for covered entities that dispense medications through contract pharmacies have resulted in overcharges and are in direct violation of the 340B statute. 1 The letters...

Share WASHINGTON, D.C. – May 25, 2021 – The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firm’s Health Care & FDA Practice. “Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firm's cultural and quality fabric his first time with us. Having him rejoin at this time speaks to his and our commitment to Washington, D.C. and to the many stakeh...

Share this article Share this article WASHINGTON, May 25, 2021 /PRNewswire/ -- The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firm's Health Care & FDA Practice. "Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firm's cultural and quality fabric his first time with us. Having him rejoin at this time speaks to his and our commitment to Washing...

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.

In Featured, News by Ged Kenslea December 30, 2020 On Wednesday, the HHS Office of the General Counsel released an advisory opinion concluding that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities   they planned to refuse to provide certain drugs at the legally required ‘340B price’ as required by section 340B of the U.S. Public Health Services Act WASHINGTON (December 30, 2020) AIDS Healthcare Foundation (AHF) welcomed and praised an advisory opini...